Funding Boost for Moon Surgical
Moon Surgical, a pioneering French-American startup, secures a substantial $55.4 million investment, led by Sofinnova Partners and NVIDIA, to propel the development of its groundbreaking Maestro System.
With recent achievements such as obtaining the CE Mark and FDA 510(k) clearance for the Maestro System, Moon establishes itself as a trailblazer in the field of collaborative robotics for surgical applications.
Investors Rally Behind Moon Surgical’s Vision
Renowned venture capital firms Sofinnova Partners and NVentures, backed by NVIDIA, spearhead the funding round, joined by esteemed investors and industry experts, reinforcing confidence in Moon Surgical’s transformative potential.
Moon Surgical’s game-changing Maestro System introduces a two-armed robotic surgical assistant, empowering laparoscopic surgeons with enhanced tissue manipulation capabilities, revolutionizing control and convenience in the operating room.
Accelerating Towards Commercialization and Continuous Innovation
Fuelled by this substantial investment, Moon gears up for the planned commercial launch of the Maestro System, while dedicating resources to further refine and advance its technology, setting the stage for market entry and widespread adoption.
Moon reinforces its leadership by appointing Fred Moll, MD, as the independent Chair of the Board, while Gérard Hascoët continues as a Board Director. Additionally, industry veterans Antoine Papiernik, Mohamed (Sid) Siddeek, and Steve Oesterle, MD, join as Board Observers, fortifying Moon Surgical’s strategic guidance and expertise.